English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:  Yang, Jing;  Kang, Heming;  Lyu, Liyang;  Xiong, Wei;  Hu, Yuanjia
Favorite | TC[WOS]:7 TC[Scopus]:7 | Submit date：2023/09/21
Bispecific Antibodies  Combination Therapy  Immuno-oncology Therapy  Kinase Inhibitors  Pd-1/pd-l1 Inhibitors  Targeted Therapy  
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis Review article
2022
Authors:  Lei, Qing;  Yan, Xin;  Zou, Huimin;  Jiang, Yixuan;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:13 TC[Scopus]:11  IF:2.8/2.8 | Submit date：2023/01/30
First-line  Immune Checkpoint Inhibitors  Meta-analysis  Network Meta-analysis  Unresectable Hepatocellular Carcinoma  
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and net Journal article
Lei, Qing, Yan, Xin, Zou, Huimin, Jiang, Yixuan, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao. Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and net[J]. Discover Oncology, 2022.
Authors:  Lei, Qing;  Yan, Xin;  Zou, Huimin;  Jiang, Yixuan;  Lai, Yunfeng; et al.
Favorite |   IF:2.8/2.8 | Submit date：2023/01/08